Sanofi and Cipla enters into distribution partnership to expand reach of CNS portfolio in India
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
Currently, Sharma is a part of the Philippines Country Leadership Team as Business Unit Head Respiratory & Immunology
Centhaquine is a resuscitative agent presently indicated for the treatment of hypovolemic shock by DGCI
This new medication eliminates the need for cold storage, making it more accessible and affordable for SCD patients across India
The plan essentially was to separate Aster’s India and GCC businesses to unlock long-term value
A five-day inspection was concluded successfully with no critical and no major observations raised
Christoph Funke's extensive career includes leadership roles at organizations such as Fresenius Kabi and Strides Pharma Science
Both organisations enter into a long- term collaboration to expand patient access in India
The first and only oral androgen deprivation therapy treatment for men with advanced prostate cancer
Subscribe To Our Newsletter & Stay Updated